Order ZstatFlu®.
		11/07/02 ZymeTx Announces Plans to Reorganize Company; Marketing, Sales and Research Activity Will Continue Through Reorganization Process 02/20/02 Zymetx Reports Second Quarter Operating Results for Period Ended December 31, 2001; Results Reflect Late Arrival Of 2001/2002 Flu Season 01/21/02 ZymeTx Board Promotes Company Co-Founder Shimasaki; Dr. Shimasaki's Responsibilities Expand to Include Oversight of Daily Operations, NFSN and International Sales 01/10/02 ZymeTx Expands Presence in Assisted-Care Market Through Product Distribution Arrangement With Advanced Laboratory Technologies 12/11/01 ZymeTx, Inc. Raises $720,000 in New Capital; New Capital Follows Record First-Quarter Sales 11/29/01 National Flu Surveillance Network Reports Flu Season Arrives in 23 States; Influenza Season Begins as Anthrax Fears Persist 11/21/01 ZymeTx Posts Dramatic First-Quarter Sales Increase; Increased Demand for the Company's ZstatFlu Rapid Diagnostic Test Spurs Record Sales Quarter 11/01/01 ZymeTx's ZstatFlu Diagnostic Test Receives All-Important Government Reimbursement in Japan 10/19/01 ZymeTx and San Antonio Lighthouse Partnership Receives JWOD Set Aside of ZstatFlu Diagnostic Test for U.S. Government Use 10/17/01 ZymeTx Reports Financial Results for the Year and Fourth Quarter Ended June 30, 2001 10/11/01 ZymeTx Launches Flu Season Surveillance Amid Bioterrorism Fears; NFSN Viewed as Potential Tool in National Counter Bioterrorism 07/25/01 ZymeTx Scientists Encouraged by Clinical Study Results On Development of New Infectious Disease Diagnostic Platform 07/12/01 ZymeTx Receives Major ZstatFlu Order From Japan; Nichirei Orders Rapid Flu Diagnostic Tests for Distribution in Japanese Market 07/02/01 National Association of Community Health Centers and ZymeTx to Promote ZstatFlu 06/28/01 ZymeTx Reverses Decision On Nasdaq Appeal, Reverse Split 06/27/01 ZymeTx and Polaroid Sign Definitive Agreement for Next Stage Development of New Viral Disease Diagnostic Technology 06/26/01 ZymeTx Moves to OTC Bulletin Board 05/15/01 ZymeTx Reports Third Quarter Operating Results 04/05/01 ZymeTx, Inc. Securities Delisting Action Stayed with Scheduled Hearing 04/04/01 ZymeTx To Present Workplace Flu Management Program To Fortune 500 Companies 04/03/01 ZymeTx, Inc. Securities Subject to Possible Delisting From Nasdaq National Market 03/30/01 ZymeTx Appoints CFO 03/29/01 ZymeTx Awarded Innovator of the Year; Viral Disease Management Company Honored with ``On the Brink'' Award for Influenza Diagnostic Product Ingenuity 03/21/01 ZymeTx and Nichirei Receive Japanese Health Ministry Approval to Market ZstatFlu in Japan; Distributor Agreement Positions ZymeTx for Immediate Entry into Large Japanese Market 02/16/01 Media and Investor Advisory: CEOcast Interviews ZymeTx President Norman Proulx; Proulx Discusses ZymeTx's Viral Disease Technology and Polaroid Research Initiative 02/13/01 ZymeTx and Polaroid Launch U.S. Clinical Trials on Next Generation Infectious Disease Diagnostic Platform; Influenza Detection Test the Initial Goal 02/12/01 ZymeTx Reports Second-Quarter Earnings for Period Ended December 31, 2000; Earnings Reflect Late 2000/2001 Flu Season 02/01/01 Distribution Agreement With Edwards Medical Supply Provides ZymeTx Immediate Access to Occupational Health Market 01/16/01 42 States Report Flu Activity; Alerts, Warnings Issued for 17 States 12/13/00 ZymeTx Officials Brief Investors and Shareholders On Company Position Entering the Winter Flu Season 12/05/00 ZstatFlu Receives FDA Waived Status; Waiver Expands Market Opportunities for ZymeTx's Rapid Flu Diagnostic Test 11/28/00 National Flu Surveillance Network Enters Flu Season With Record Physician Participation
			ZymeTx Web Sites: zymetx.com flu101.com fluwatch.com ©2003 - ZymeTx, Inc. ZstatFlu®, ViraZyme®, and ViraSTAT® are trademarks of ZymeTx, Inc.